Back to Search

TEDRA GILMORE, MD

MD

Obstetrics & Gynecology Physician

NPI: 1205928223IndividualAccepts Medicare

Specialties, Licenses & Credentials

Obstetrics & Gynecology PhysicianPrimary

Obstetrics & Gynecology

Code: 207V00000X

ME 98980(FL)2022-02131(NC)

CMS Specialties

PrimaryOBSTETRICS/GYNECOLOGY

Education

DREXEL UNIVERSITY COLLEGE OF MEDICINE

Class of 2002

Research & Publications (20)

Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression.
PMID 18570704·Int J Neuropsychopharmacol·2009
8-other
Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.
PMID 19377508·Oncogene·2009
7-preclinical
Getting away from it all in Capri: the 2008 EMBO workshop on NF-kappaB.
PMID 19287453·Cell Death Differ·2009
8-other
Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitors.
PMID 19356929·Bioorg Med Chem Lett·2009
7-preclinical
Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL.
PMID 18695674·Oncogene·2008
7-preclinical
Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation.
PMID 19110719·Gene Expr·2008
7-preclinical
Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347.
PMID 18164680·Biochem Biophys Res Commun·2008
7-preclinical
Alternative splicing in the NF-kappaB signaling pathway.
PMID 18718859·Gene·2008
6-review
Rel homology domain-containing transcription factors in the cnidarian Nematostella vectensis.
PMID 17120026·Dev Genes Evol·2007
7-preclinical
Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
PMID 17072339·Oncogene·2007
7-preclinical
Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists.
PMID 17681466·Bioorg Med Chem Lett·2007
8-other
Multiple myeloma: lusting for NF-kappaB.
PMID 17692798·Cancer Cell·2007
6-review
Mutations in the NF-kappaB signaling pathway: implications for human disease.
PMID 17072331·Oncogene·2006
6-review
Inhibitors of NF-kappaB signaling: 785 and counting.
PMID 17072334·Oncogene·2006
6-review
The synthetic epoxyquinoids jesterone dimer and epoxyquinone A monomer induce apoptosis and inhibit REL (human c-Rel) DNA binding in an IkappaBalpha-deficient diffuse large B-cell lymphoma cell line.
PMID 16289774·Cancer Lett·2006
8-other
Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity.
PMID 16360644·Biochem Pharmacol·2006
7-preclinical
Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
PMID 16386422·Bioorg Med Chem Lett·2006
4-observational
Good cop, bad cop: the different faces of NF-kappaB.
PMID 16410803·Cell Death Differ·2006
6-review
Introduction to NF-kappaB: players, pathways, perspectives.
PMID 17072321·Oncogene·2006
6-review
Quinol-4-ones as steroid A-ring mimetics in nonsteroidal dissociated glucocorticoid agonists.
PMID 17181172·J Med Chem·2006
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
7141 SECURITY BLVD
BALTIMORE, MD 21244

Locations (2)

Practice Location

7141 SECURITY BLVD, BALTIMORE, MD
(800) 777-7904

Practice Location

105 MCALPINE LN, LAURINBURG, NC
(910) 504-8530

Quick Facts

NPI
1205928223
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
24
Publications
20

Are you this provider?

Claim Your Profile